The 2019 guidelines are designed to be enduring, unlike prior versions which required major updates every 5-10 years to adjust with emerging evidence. As a result, guidelines can become out of date rapidly—years before the scheduled next cycle. With an enduring consensus committee, the principle of ‘equal management for equal risk’, and the Clinical Action Thresholds of the 2019 guidelines, new technologies and approaches can be incorporated into the new guidelines framework as they become available. A standing consensus committee, including representatives from professional medical societies, federal agencies, and patient advocacy organizations, will continue to evaluate and ratify risk estimations and review population characteristics as they may change with the increasing impact of vaccination. The committee publishes updates to the risk tables and facilitates the dissemination of the new data to clinicians.